Aster DM Healthcare Ltd

Aster DM Quality Care Q1 Results: Revenue Up, But Merger Costs Impact Bottom Line 📊

- Standalone Q1 revenue from operations reached INR 725.73 crores, up from INR 613.04 crores in the same quarter last year.

- Standalone Q1 reported a net loss of INR 14.30 crores, compared to a net profit of INR 80.59 crores in Q1 previous year.

- The loss includes an exceptional item expense of INR 109.79 crores related to merger costs.

- Excluding this exceptional item, standalone profit before tax was INR 120.68 crores.

- The company's name changed to Aster DM Quality Care Limited effective 1 July 2026 following a sanctioned merger.

- The company increased its stake in subsidiary Malabar Institute of Medical Sciences Limited to 81.29% with an additional investment of INR 31.40 crores.

- Additional investments were made in wholly owned subsidiary Aster DM-Super Specialty Hospital (Sarjapur) Private Limited (INR 45.09 crores) and associate Alfaone Medicals Private Limited (INR 25.00 crores).

- Consolidated results, including 16 subsidiaries, showed a total revenue of INR 61.53 crores and a loss after tax of INR 4.41 crores for the quarter.

- Standalone basic earnings per share (EPS) for Q1 is negative INR 0.28.